ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Enanta Pharmaceuticals Announces the Planned Retirement of CMO Nathalie Adda
July 15, 2021Enanta today announced that Nathalie Adda, M.D., Senior Vice President and Chief Medical Officer, will retire from Enanta in February 2022 and continue to serve as a consultant to the company thereafter. -
Enanta Pharmaceuticals Reports Positive Data from Phase 1b Study of EDP-514, a Hepatitis B Virus (HBV) Core Inhibitor, in Viremic Chronic HBV Patients
June 23, 2021Enanta Pharmaceuticals, Inc. today announced positive data from the first two dose cohorts of its Phase 1b study of EDP-514 in viremic chronic HBV patients who were not being treated with a nucleoside reverse transcriptase inhibitor (NUC).
Pharma Sources Insight January 2025
